Osceola Senior Living

In the surveyor’s words

From the most serious findings on record at Osceola Senior Living, in the surveyor’s own words.

• No harm, potential for more than minimal, isolatedF695Apr 2, 2026

  Based on observations, record review, and interviews, the facility failed to implement and practice appropriate infection control measures by not establishing or following a routine cleaning schedule for continuous positive airway pressure (CPAP) equipment for 1 of 13 residents reviewed (Resident #17). The facility also failed to provide staff with current CPAP machine settings. The facility reported a census of 32 residents. Findings include:The Minimum Data Set (MDS) assessment dated [DATE] for Resident #17 documented diagnoses of anemia, coronary artery disease (CAD) and dementia. The MDS indicated Resident #7 used a non-invasive mechanical ventilator. […]

• No harm, potential for more than minimal, isolatedF658Mar 13, 2025

  Based on record review and staff interviews the facility failed to provide professional standards of care by not following physician orders to include the updated order and the correct medication end date in the electronic record for 2 out of 12 residents reviewed (Resident #3 and #31). The facility reported a census of 34 residents. Findings include: 1. The Minimum Data Set (MDS) assessment dated [DATE] for Resident #3 documented diagnoses of Alzheimer's Disease, stroke, and hypertension. The MDS showed the Brief Interview for Mental Status (BIMS) score of 5, which indicated severe cognitive impairment. The Consultant Pharmacist Report for Resident #3 showed on 2/13/25 the physician reordered the as needed (PRN) lorazepam for a duration of 12 months. […]

• No harm, potential for more than minimal, isolatedF695Mar 13, 2025

  Based on observation, record review, and staff interview the facility failed to ensure a resident received Oxygen (O2) per the physician's order for 1 resident reviewed (Resident #25). The facility reported a census of 34 residents. Findings include: According to the Minimum Data Set (MDS) assessment dated [DATE] Resident #25 scored 12 on the Brief Interview for Mental Status (BIMS) indicating moderate cognitive impairment. The resident had diagnoses including atrial fibrillation, heart failure, and a fracture. The resident did not receive oxygen (O2). The Care Plan initiated 1/8/25 identified the resident with an alteration in tissue perfusion related to Congestive Heart Failure (CHF), Atrial-fibrillation, and pulmonary hypertension. […]

• No harm, potential for more than minimal, isolatedF744Mar 13, 2025

  Based on clinical record review and staff interview the facility failed to address dementia/Alzheimer's Disease care on the care plan for 1 out of 5 residents reviewed (Resident #3). The facility reported a census of 34 residents. Findings include: 1. The Minimum Data Set (MDS) assessment dated [DATE] for Resident #3 documented diagnoses of Alzheimer's Disease, stroke, and hypertension. The MDS showed the Brief Interview for Mental Status (BIMS) score of 5, which indicated severe cognitive impairment. The Care Plan for Resident #3 lacked information regarding the physical, mental and psychosocial needs to support the highest practical level of well being for a resident with Alzheimer's Disease or dementia. […]

• No harm, potential for more than minimal, isolatedF758Mar 13, 2025

  Based on clinical record review and staff interview the facility failed to identify side effects, non-pharmalogical interventions to try prior to medication and specific targeted behaviors related to high risk medications in 2 out of 5 sampled residents reviewed (Resident #3 and #9). The facility reported a census of 34 residents. Findings include: 1. The Minimum Data Set (MDS) assessment dated [DATE] for Resident #3 documented diagnoses of Alzheimer's Disease, stroke, and hypertension. The MDS showed the Brief Interview for Mental Status (BIMS) score of 5, which indicated severe cognitive impairment. The Clinical Physician Orders for Resident #3 showed the following orders: a. Lorazepam (antianxiety medication) with a start date of 1/5/25, b. […]